Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Barbara Hutz"'
Autor:
Sharmaine Reintar, Magdalena Pöchhacker, Anna Obermayer, Katharina Eberhard, Andreas Zirlik, Nicolas Verheyen, Dirk von Lewinski, Daniel Scherr, Barbara Hutz, Christoph W. Haudum, Thomas R. Pieber, Harald Sourij, Barbara Obermayer-Pietsch
Publikováno v:
Nutrients, Vol 15, Iss 9, p 2073 (2023)
Background: C-peptide is produced in equimolar amounts with insulin from pancreatic beta cells, and thus is a fundamental biomarker for beta cell function. A non-invasive urinary C-peptide-to-creatinine ratio (UCPCR) has attracted attention as a biom
Externí odkaz:
https://doaj.org/article/e2574249a8ba477f9119e9c826780727
Autor:
Burkert Pieske, Gerald Seidel, Andreas Zirlik, Thomas R Pieber, Andreas Wedrich, Andreas Tomaschitz, Markus Wallner, Elisabeth Pieske-Kraigher, Christoph Walter Haudum, Ewald Kolesnik, Caterina Colantonio, Ines Mursic, Marion Url-Michitsch, Theresa Glantschnig, Barbara Hutz, Alice Lind, Natascha Schweighofer, Clemens Reiter, Klemens Ablasser, Norbert Joachim Tripolt, Tobias Madl, Alexander Springer, Thomas Krahn, Rudolf Stauber, Nicolas Verheyen, Barbara Obermayer-Pietsch, Albrecht Schmidt
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Purpose Accumulating evidence points towards a close relationship between cardiovascular, endocrine and metabolic diseases. The BioPersMed Study (Biomarkers of Personalised Medicine) is a single-centre prospective observational cohort study with repe
Externí odkaz:
https://doaj.org/article/cbd7304968f74fe98cf73ab979fc73c0
Autor:
Natascha Schweighofer, Caterina Colantonio, Christoph W. Haudum, Barbara Hutz, Ewald Kolesnik, Ines Mursic, Stefan Pilz, Albrecht Schmidt, Vanessa Stadlbauer, Andreas Zirlik, Thomas R. Pieber, Nicolas Verheyen, Barbara Obermayer-Pietsch
Publikováno v:
Nutrients, Vol 14, Iss 1, p 186 (2021)
Sarcopenia is linked with increased risk of falls, osteoporosis and mortality. No consensus exists about a gold standard “dual-energy X-ray absorptiometry (DXA) index for muscle mass determination” in sarcopenia diagnosis. Thus, many indices exis
Externí odkaz:
https://doaj.org/article/da8475cc15f842c0b1d601844269fc4d
Autor:
Veronika Tandl, Christoph W. Haudum, Katharina Eberhard, Barbara Hutz, Ewald Kolesnik, Albrecht Schmidt, Andreas Zirlik, Lewinski Dirk von, Daniel Scherr, Nicolas Verheyen, Thomas R. Pieber, Barbara Obermayer-Pietsch
Publikováno v:
Endocrine Abstracts.
Autor:
Natascha Schweighofer, Caterina Colantonio, Christoph W. Haudum, Barbara Hutz, Ewald Kolesnik, Ines Mursic, Stefan Pilz, Albrecht Schmidt, Vanessa Stadlbauer, Andreas Zirlik, Thomas R. Pieber, Nicolas Verheyen, Barbara Obermayer-Pietsch
Publikováno v:
Nutrients, Vol 14, Iss 186, p 186 (2022)
Nutrients
Nutrients; Volume 14; Issue 1; Pages: 186
Nutrients
Nutrients; Volume 14; Issue 1; Pages: 186
Sarcopenia is linked with increased risk of falls, osteoporosis and mortality. No consensus exists about a gold standard “dual-energy X-ray absorptiometry (DXA) index for muscle mass determination” in sarcopenia diagnosis. Thus, many indices exis
Autor:
Veronika Tandl, Caterina Colantonio, Christoph W Haudum, Barbara Hutz, Ewald Kolesnik, Albrecht Schmidt, Andreas Zirlik, Nicolas Verheyen, Thomas R Pieber, Barbara Obermayer-Pietsch
Publikováno v:
Endocrine Abstracts.
Autor:
Natascha Schweighofer, Caterina Colantonio, Christoph W Haudum, Barbara Hutz, Ewald Kolesnik, Albrecht Schmidt, Andreas Zirlik, Thomas R Pieber, Nicolas Verheyen, Barbara Obermayer-Pietsch
Publikováno v:
Endocrine Abstracts.
Autor:
Christoph Walter Haudum, Ewald Kolesnik, Caterina Colantonio, Ines Mursic, Marion Url-Michitsch, Andreas Tomaschitz, Theresa Glantschnig, Barbara Hutz, Alice Lind, Natascha Schweighofer, Clemens Reiter, Klemens Ablasser, Markus Wallner, Norbert Joachim Tripolt, Elisabeth Pieske-Kraigher, Tobias Madl, Alexander Springer, Gerald Seidel, Andreas Wedrich, Andreas Zirlik, Thomas Krahn, Rudolf Stauber, Burkert Pieske, Thomas R Pieber, Nicolas Verheyen, Barbara Obermayer-Pietsch, Albrecht Schmidt
Publikováno v:
BMJ open. 12(4)
PurposeAccumulating evidence points towards a close relationship between cardiovascular, endocrine and metabolic diseases. The BioPersMed Study (Biomarkers of Personalised Medicine) is a single-centre prospective observational cohort study with repet
Autor:
Franz Hafner, Barbara Hutz, Marianne Brodmann, Norbert J. Tripolt, Regina Riedl, Ronald Hödl, Gudrun Dimsity, Tatjana Stojakovic, Andreas Meinitzer, Felix Aberer, Harald Sourij, Jasmin Url
Publikováno v:
Trials
Background Patients with type 2 diabetes (T2DM) are at increased risk for macrovascular events as well as for microvascular complications. There is evidence that in patients with coronary artery disease (CAD), about 35 % suffer from manifest T2DM. Ea